By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Immune Pharmaceuticals, Inc. 

150 Broadway
Suite 1801
New York  New York  10038  U.S.A.
Phone: 646-937-1941 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Immune Pharmaceuticals, Inc. Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 7/30/2014 8:01:42 AM
Immune Pharmaceuticals, Inc. Release: Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 7/24/2014 9:04:54 AM
Immune Pharmaceuticals, Inc. Appoints Cameron Durrant, MD, MBA To Board Of Directors 7/14/2014 5:59:30 AM
Immune Pharmaceuticals, Inc. Partners With Patient Community Group LYFEBULB 6/25/2014 8:13:33 AM
Immune Pharmaceuticals, Inc. Appoints Gad Berdugo To Board Of Directors And Karin Hehenberger, M.D., Ph.D To Senior Vice President 6/6/2014 9:29:09 AM
Immune Pharmaceuticals, Inc. Announces First Quarter 2014 Financial Results 5/21/2014 9:34:24 AM
Immune Pharmaceuticals, Inc. Announces Phase 3 Development And Commercialization Strategy For AMIKET 5/5/2014 9:10:23 AM
Immune Pharmaceuticals, Inc. Announces Company Highlights And Reports Full Fiscal Year 2013 Financial Results 4/10/2014 7:53:33 AM
Immune Pharmaceuticals, Inc. CEO Announces New Operational Leadership Team 4/2/2014 9:14:08 AM
Immune Pharmaceuticals, Inc. Scores $11.7 Million Private Placement Financing 3/10/2014 9:57:16 AM
12345
//-->